Earlier today, Dr. Johanna Bendell, Director of GI Cancer Research Program at Sarah Cannon, the Cancer Institute of HCA, appeared on CNN with MichaeLA to discuss a recent study showing that the number of cases of colorectal cancer is rising for younger generations. Dr. Bendell sheds light on risk factors being researched that may be influencing the rising incidence rates for younger generations – while rates for older generations are decreasing. Learn more about the ongoing discussions regarding screening, potential risk factors and symptoms for younger generations from Dr. Bendell. HCA internal audience can view national segment here.
Being diagnosed with cancer can be overwhelming – as you learn new terminology, create a treatment plan with your care team and adjust your daily life to new appointments and physical challenges. Talking to your kids about your diagnosis is an added layer to this journey. Sarah Cannon, the cancer institute of HCA, provides resources and support, including an oncology trained nurse navigator, to walk with you through your journey. Elissa Redding, gastrointestinal nurse navigator at Sarah Cannon Cancer Institute at Swedish Medical Center in Denver, shares her insights on how to approach talking to children (both young and old)… Read more.
Last week, Sarah Cannon, our global cancer institute, and HCA Midwest Health, Kansas City’s largest healthcare network, announced that they expanded their cancer collaboration through clinical research. By joining a global research network, HCA Midwest Health is now offering greater access to clinical trials for those facing cancer in the Kansas City region. “Clinical trials are an integral part of advancing the standard of cancer care, as today’s trials are tomorrow’s cutting-edge treatments,” said Dr. Howard A. “Skip” Burris, III, president of clinical operations and chief medical officer at Sarah Cannon. “By expanding our collaboration, we can provide patients in… Read more.
Dr. Erika Hamilton, Associate Director, Breast Cancer and Gynecologic Cancer Research Program at Sarah Cannon Research Institute – the research arm of our global cancer enterprise, Sarah Cannon – was featured on CNN today regarding the American Cancer Society’s new screening guidelines just released. New screening guidelines state that women should begin getting mammograms at age 45 instead of 40 and all women can forego routine manual breast checks by physicians. One of the reasons surrounding these changes are that mammograms have a fairly high false-positive rate and the chance of false-positives increase under age 45 as women in this… Read more.
Dr. Johanna Bendell, Director of the GI Cancer Research Program and Associate Director of the Drug Development Program at Sarah Cannon Research Institute – the research arm of HCA’s global cancer enterprise Sarah Cannon – was featured on CNN, Fox News, and MSNBC Thursday morning to provide insight on former U.S. President Jimmy Carter’s recent cancer announcement. Dr. Bendell discusses the brief statement released by the former president and the positive impact the president’s active lifestyle may have on his treatment options. Sarah Cannon provides state-of-the-art cancer care and access to clinical trials close to home for hundreds of thousands… Read more.
Sarah Cannon cancer experts and leadership appeared on Fox & Friends on Wednesday, April 29 to discuss the encouraging advances being made in cancer care. Sarah Cannon, HCA’s global cancer enterprise, is a world leader in clinical trials and immunotherapy, conducting more than 500 clinical trials annually. In the Fox & Friends segment, Sarah Cannon’s CEO, Dee Anna Smith, along with Drs. Burris, Bendell, Hamilton and Spigel gave updates on the research surrounding colon, breast and lung cancers. View the segment here or watch below:
Breakthroughs in cancer research have been gaining momentum over the last few years, and particularly in 2014 when the U.S. Food and Drug Administration (FDA) approved 19 new cancer drugs. Sarah Cannon, HCA’s global cancer enterprise, was instrumental in advancing 13 of these new therapies through clinical trials prior to their original FDA approval. Over its 20-year history of bringing clinical trials closer to patients in a community setting, Sarah Cannon has been able to see thousands of patients benefit from such new treatment options.
We’re excited to share that HCA has been named a 2013 Laureate in IDG’s Computerworld Honors Program for a Cancer Navigation Solution to better care for cancer patients throughout treatment. The solution was developed jointly by HCA Information Technology and Services (IT&S) and Sarah Cannon, HCA’s global cancer service line.
My cancer diagnosis came in May of 2007 after months of feeling like something was not right with my health. I was getting sick frequently and the illnesses would linger for weeks at a time. I noticed that the lymph nodes under my jaw and in my neck were enlarged and I was always tired and could not get through an evening without a nap after work. I had seen a doctor for some tests, but nothing significant showed up. A few months later, I asked for a complete physical with blood work and that is when the red flags… Read more.